hosted by

Domenico De Berardis

Head, Department of Mental Health, Asl 4 Teramo, Italy.

Contract Professor of Psychiatry, University of L'Aquila, Italy.

International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, Russia.
Domenico De Berardis holds both Ph.D. and M.D. degrees. He works as a Psychiatrist in the "real world" clinical practice and, to date, is director of the Department of Mental Health of Teramo. He collaborates independently with the Institute of Psychiatry of G. d’Annunzio University Chieti-Pescara, Italy and is Visiting Professor and Senior Researcher at the International Centre for Education and Research in Neuropsychiatry of the University of Samara (Russia). He is specialized in Medicina Delle Farmacotossicodipendenze, has attained a Ph.D. in Functional Neuroimaging at the Institute for Advanced Biomedical Technologies (ITAB) of the University G. D'Annunzio of Chieti and has a master in Clinical Psychopharmacology obtained at the University Vita-Salute San Raffaele of Milano. He also achieved a master in Healthcare Communication in 2013 at the University of Teramo. He is trained in Cognitive-Behavioral Therapy (CBT) and works as a psychotherapist too, mainly treating patients with personality disorders and OCD. He is the principal investigator of several research projects, mostly related to alexithymia, anxiety disorders, suicide, schizophrenia, neuroimaging, and clinical psychopharmacology. He has published over 230 articles with an impact factor, with an h-index of 59 (9985 citations, Google Scholar, 2023) and 48 (6339 citations, Scopus, 2023). He has frequently participated in national and international congresses as a speaker or through oral or written communications. These papers and several book chapters reflect his main research lines and areas of recognized expertise on alexithymia, anxiety and mood disorders, functional magnetic resonance, and clinical psychopharmacology. He regularly collaborates with professors and researchers from other universities in Italy, European, the US, and Indian countries. His professional activities also include reviewing scientific manuscripts (more than 1000, March 2023) for high-impact journals and is a member of the Editorial Board of Journal of Clinical Medicine, Brain Sciences, BMC Psychiatry, CNS & Neurological Disorders - Drug Targets, Depression Research and Treatment, Alpha Psychiatry, Women, Psychiatry International, Diseases, Current Drug Therapy, Current Drug Discovery Technologies, Current Psychopharmacology, The Open Biology Journal, ISRN Psychiatry, Annals of Depression and Anxiety, International Journal of Clinical Toxicology, Journal of Psychology and Psychotherapy Research, Bipolar Disorder: Open Access, Journal of Neuropsychopharmacology and Mental Health, Journal of Advanced Biomarkers Research and Journal of Sleep Medicine and Disorders. He is Associate Editor of Research and Advances in Psychiatry and Academic Editor of the British Journal of Medicine and Medical Research. He also serves as Review Editor in Neurodegeneration and Addictive Disorders for Frontiers in Neuroscience (IF 3.398), Frontiers in Psychiatry, and Frontiers in Neurology (IF 3.184).
He was included in the 'Stanford University World's Top Scientists 2022' list of the most cited and influential scientists (the list represents the top 2% of the world's best scientists in various disciplines).
He is Editor in Chief of the journal Mental Illness published by Hindawi Press (

Web of Science Page:
Researchgate page:
ICERP University of Samara (Russia):
Italian Webpage:
Powered by